These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 22344043)
21. A comprehensive analysis of p16 expression, gene status, and promoter hypermethylation in surgically resected non-small cell lung carcinomas. Sterlacci W; Tzankov A; Veits L; Zelger B; Bihl MP; Foerster A; Augustin F; Fiegl M; Savic S J Thorac Oncol; 2011 Oct; 6(10):1649-57. PubMed ID: 21857254 [TBL] [Abstract][Full Text] [Related]
22. Tumor suppressor gene p16 (CDKN2A) mutation status and promoter inactivation in head and neck cancer. Riese U; Dahse R; Fiedler W; Theuer C; Koscielny S; Ernst G; Beleites E; Claussen U; von Eggeling F Int J Mol Med; 1999 Jul; 4(1):61-5. PubMed ID: 10373639 [TBL] [Abstract][Full Text] [Related]
23. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma. Zhang YJ; Ahsan H; Chen Y; Lunn RM; Wang LY; Chen SY; Lee PH; Chen CJ; Santella RM Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038 [TBL] [Abstract][Full Text] [Related]
24. Promoter hypermethylation of death-associated protein kinase and p16 genes in vulvar lichen sclerosus. Aidé S; Lattario FR; Almeida G; do Val IC; Carvalho Mda G J Low Genit Tract Dis; 2012 Apr; 16(2):133-9. PubMed ID: 22371043 [TBL] [Abstract][Full Text] [Related]
25. Association between P16INK4a Promoter Methylation and Ovarian Cancer: A Meta-Analysis of 12 Published Studies. Xiao X; Cai F; Niu X; Shi H; Zhong Y PLoS One; 2016; 11(9):e0163257. PubMed ID: 27648827 [TBL] [Abstract][Full Text] [Related]
26. Mutational analysis of selected genes in the TGFbeta, Wnt, pRb, and p53 pathways in primary uveal melanoma. Edmunds SC; Kelsell DP; Hungerford JL; Cree IA Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):2845-51. PubMed ID: 12202501 [TBL] [Abstract][Full Text] [Related]
27. Promoter hypermethylation patterns of death-associated protein kinase and p16 genes in vulvar lichen sclerosus. Aidé S; Lattario FR; Almeida G; do Val IC; Carvalho Mda G J Low Genit Tract Dis; 2010 Oct; 14(4):282-6. PubMed ID: 20885153 [TBL] [Abstract][Full Text] [Related]
28. Possible involvement of hMLH1, p16(INK4a) and PTEN in the malignant transformation of endometriosis. Martini M; Ciccarone M; Garganese G; Maggiore C; Evangelista A; Rahimi S; Zannoni G; Vittori G; Larocca LM Int J Cancer; 2002 Dec; 102(4):398-406. PubMed ID: 12402310 [TBL] [Abstract][Full Text] [Related]
29. Establishment of two data mining models of lung cancer screening based on three gene promoter methylations combined with telomere damage. Wang W; Feng X; Duan X; Tan S; Wang S; Wang T; Feng F; Wu Y; Wu Y Int J Biol Markers; 2017 Mar; 32(1):e141-e146. PubMed ID: 27716889 [TBL] [Abstract][Full Text] [Related]
30. The high frequency of de novo promoter methylation in synchronous primary endometrial and ovarian carcinomas. Furlan D; Carnevali I; Marcomini B; Cerutti R; Dainese E; Capella C; Riva C Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3329-36. PubMed ID: 16740754 [TBL] [Abstract][Full Text] [Related]
31. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers. Belinsky SA; Palmisano WA; Gilliland FD; Crooks LA; Divine KK; Winters SA; Grimes MJ; Harms HJ; Tellez CS; Smith TM; Moots PP; Lechner JF; Stidley CA; Crowell RE Cancer Res; 2002 Apr; 62(8):2370-7. PubMed ID: 11956099 [TBL] [Abstract][Full Text] [Related]
32. p16INK4A alterations are accompanied by aberrant protein immunostaining in endometrial carcinomas. Semczuk A; Boltze C; Marzec B; Szczygielska A; Roessner A; Schneider-Stock R J Cancer Res Clin Oncol; 2003 Oct; 129(10):589-96. PubMed ID: 12920579 [TBL] [Abstract][Full Text] [Related]
33. DNA content and methylation of p16, DAPK and RASSF1A gene in tumour and distant, normal mucosal tissue of head and neck squamous cell carcinoma patients. Laytragoon-Lewin N; Chen F; Castro J; Elmberger G; Rutqvist LE; Lewin F; Turesson I; Lundgren J Anticancer Res; 2010 Nov; 30(11):4643-8. PubMed ID: 21115918 [TBL] [Abstract][Full Text] [Related]
34. p16 overexpression: a potential early indicator of transformation in ovarian carcinoma. Shigemasa K; Hu C; West CM; Clarke J; Parham GP; Parmley TH; Korourian S; Baker VV; O'Brien TJ J Soc Gynecol Investig; 1997; 4(2):95-102. PubMed ID: 9101469 [TBL] [Abstract][Full Text] [Related]
35. Promoter hypermethylation of p16 and APC in gastrointestinal cancer patients. Erdem B; Küçükyıldırım S; Sağlar E; Polat Z; Mergen H Turk J Gastroenterol; 2014 Oct; 25(5):512-7. PubMed ID: 25417611 [TBL] [Abstract][Full Text] [Related]
36. Clinicopathological roles of alterations of tumor suppressor gene p16 in papillary thyroid carcinoma. Lam AK; Lo CY; Leung P; Lang BH; Chan WF; Luk JM Ann Surg Oncol; 2007 May; 14(5):1772-9. PubMed ID: 17195959 [TBL] [Abstract][Full Text] [Related]
37. Expression and promoter methylation status of mismatch repair gene hMLH1 and hMSH2 in epithelial ovarian cancer. Zhang H; Zhang S; Cui J; Zhang A; Shen L; Yu H Aust N Z J Obstet Gynaecol; 2008 Oct; 48(5):505-9. PubMed ID: 19032668 [TBL] [Abstract][Full Text] [Related]
38. No evidence exists for methylation inactivation of the p16 tumor suppressor gene in ovarian carcinogenesis. Ryan A; Al-Jehani RM; Mulligan KT; Jacobs IJ Gynecol Oncol; 1998 Jan; 68(1):14-7. PubMed ID: 9454653 [TBL] [Abstract][Full Text] [Related]
39. Methylation of tumor suppressor gene p16 and prognosis of epithelial ovarian cancer. Katsaros D; Cho W; Singal R; Fracchioli S; Rigault De La Longrais IA; Arisio R; Massobrio M; Smith M; Zheng W; Glass J; Yu H Gynecol Oncol; 2004 Sep; 94(3):685-92. PubMed ID: 15350359 [TBL] [Abstract][Full Text] [Related]
40. Epigenetic alteration of p16INK4a gene in dedifferentiation of liposarcoma. He M; Aisner S; Benevenia J; Patterson F; Harrison LE; Hameed M Pathol Res Pract; 2009; 205(6):386-94. PubMed ID: 19186005 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]